Target Name: SEPTIN10
NCBI ID: G151011
Review Report on SEPTIN10 Target / Biomarker Content of Review Report on SEPTIN10 Target / Biomarker
SEPTIN10
Other Name(s): SEP10_HUMAN | SEPT10 | OTTHUMP00000207016 | Septin 10, transcript variant 2 | septin 10 | Sept1-like | SEPTIN10 variant 1 | OTTHUMP00000207018 | SEPTIN10 variant 2 | Septin-10 | FLJ11619 | Septin 10, transcript variant 1 | OTTHUMP00000207017

SEPTIN10: A Potential Drug Target for Neurodegenerative Diseases

SEPTIN10 (SEP10_HUMAN) is a protein that is expressed in various tissues of the human body, including the brain, heart, and blood vessels. It is a key component of the cytoskeleton, which is the structure that gives cells their shape and supports their growth and movement.

SEPTIN10 is also involved in cell signaling, which is the process by which cells communicate with each other to coordinate their activities. It plays a role in the regulation of cell division, and is also involved in the development and maintenance of tissues.

SEPTIN10 is a protein that has been identified as a potential drug target in the field of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. These conditions are characterized by the progressive loss of brain cells, and are often associated with a range of symptoms, including cognitive decline and progressive physical disability.

One of the reasons why SEPTIN10 is thought to be a promising drug target is because it is involved in the development and maintenance of the cytoskeleton, which is a critical structure that helps to support the growth and development of tissues. As the cytoskeleton is broken down, it can be thought of as a \"skeleton for cells,\" and is involved in the regulation of cell movement and division.

In addition, SEPTIN10 is also involved in the regulation of cell signaling, which is the process by which cells communicate with each other to coordinate their activities. This is important for the regulation of cell growth, differentiation, and development, as well as for the regulation of the immune system.

SEPTIN10 is also involved in the development and maintenance of tissues, such as the brain and heart. It is a key component of the cytoskeleton, and is thought to be involved in the regulation of the structure and function of these tissues.

In conclusion, SEPTIN10 is a protein that is expressed in various tissues of the human body, and is involved in the development and maintenance of the cytoskeleton, as well as the regulation of cell signaling and the development and maintenance of tissues. As a result, it is a potential drug target for the treatment of neurodegenerative diseases. Further research is needed to fully understand the role of SEPTIN10 in these conditions, and to determine the most effective way to use it as a drug.

Protein Name: Septin 10

Functions: Filament-forming cytoskeletal GTPase. May play a role in cytokinesis (Potential)

The "SEPTIN10 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SEPTIN10 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SEPTIN11 | SEPTIN12 | SEPTIN14 | SEPTIN2 | SEPTIN3 | SEPTIN4 | SEPTIN4-AS1 | SEPTIN5 | SEPTIN6 | SEPTIN7 | SEPTIN7-DT | SEPTIN7P11 | SEPTIN7P14 | SEPTIN7P2 | SEPTIN7P6 | SEPTIN7P9 | SEPTIN8 | SEPTIN9 | SERAC1 | SERBP1 | SERBP1P3 | SERF1A | SERF1B | SERF2 | SERF2-C15ORF63 | SERGEF | SERHL | SERINC1 | SERINC2 | SERINC3 | SERINC4 | SERINC5 | Serine (or cysteine) proteinase inhibitor clade F | Serine palmitoyltransferase | Serine protease | Serine protease inhibitor | Serine-aspartate repeat-containing protein I-like | SERP1 | SERP2 | SERPINA1 | SERPINA10 | SERPINA11 | SERPINA12 | SERPINA13P | SERPINA2 | SERPINA3 | SERPINA4 | SERPINA5 | SERPINA6 | SERPINA7 | SERPINA9 | SERPINB1 | SERPINB10 | SERPINB11 | SERPINB12 | SERPINB13 | SERPINB2 | SERPINB3 | SERPINB4 | SERPINB5 | SERPINB6 | SERPINB7 | SERPINB8 | SERPINB9 | SERPINB9-AS1 | SERPINB9P1 | SERPINC1 | SERPIND1 | SERPINE1 | SERPINE2 | SERPINE3 | SERPINF1 | SERPINF2 | SERPING1 | SERPINH1 | SERPINI1 | SERPINI2 | SERTAD1 | SERTAD2 | SERTAD3 | SERTAD4 | SERTAD4-AS1 | SERTM1 | SERTM2 | Serum amyloid protein | SESN1 | SESN2 | SESN3 | SESTD1 | Sestrin | SET | SET1 histone methyltransferase complex | SETBP1 | SETBP1-DT | SETD1A | SETD1B | SETD2 | SETD3 | SETD4 | SETD4-AS1